跳至主要内容
临床试验/CTRI/2025/06/088585
CTRI/2025/06/088585尚未招募2/3 期

A Randomized controlled clinical study of Dadimadi Churna in the management of Kaphaja kasa chronic bronchitis.

Dr Kadam Rutuja Dharmaraj1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2025年6月18日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
发起方
入组人数
40
试验地点
1
主要终点
KASA (COUGH)

研究概览

简要总结

AIM OF THE STUDY

To evaluate the efficacy of Dadimadi Churna in the management of Kaphaja Kasa.

OBJECTIVES OF STUDY

1.To prepare Dadimadi Churna as per classical method.

2.To compare the therapeutic effects of Dadimadi Churna with Bruhatsharkarasama Churna in the management of Kaphaja Kasa.

HYPOTHESIS

H0 - There is neither statistically significant difference between Dadimadi Churna and Bruhatsharkarasama Churna nor Dadimadi Churna is better than Bruhatsharkarasama Churna in the management of Kaphaja Kasa.

H1 - There is statistically significant difference in the effect of Dadimadi Churna and Bruhatsharkarasama Churna with Dadimadi Churna having better effect than Bruhatsharkarasama Churna in the management of Kaphaja Kasa.

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Participant Blinded

入排标准

年龄范围
16.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Patients who fulfill diagnostic criteria.
  • Patients with age group between 16 to 60 years.
  • Patients willing to participate in the study and ready to sign informed consent form.

排除标准

  • Patients having Productive cough with complications like: Tuberculosis, Emphysema or Pneumonia, Bronchial Asthma, Cystic fibrosis.
  • Patients with any other systemic and metabolic disorder which may interfere the study will be excluded.
  • Pregnant women and Lactating mothers will be excluded.
  • Patients undergoing steroid therapy.

结局指标

主要结局

KASA (COUGH)

时间窗: 15 days

SLIMY AND PRODUCTIVE,COUGH

时间窗: 15 days

EXPECTORANT COUGH

时间窗: 15 days

次要结局

  • Peenasa (RUNNING NOSE)(Aasyamadhurya (DISSONANCE))

研究者

发起方
Dr Kadam Rutuja Dharmaraj
申办方类型
Other [self]

研究点 (1)

Loading locations...

相似试验